Inhibrx Prospective Colorectal Cancer Treatment Shows Encouraging Results, Trial Expansion Planned
In This Article:
Inhibrx Biosciences (INBX) late Tuesday released preliminary safety and efficacy data from phase 1 t
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.